| scholarly article | Q13442814 |
| P2093 | author name string | Chien-Hsiung Pan | |
| Mei-Yu Chen | |||
| Jia-Ying Yan | |||
| Chen-Yi Chiang | |||
| Hsin-Wei Chen | |||
| Szu-Hsien Wu | |||
| Yu-Ju Hsiao | |||
| Tsung-Han Lin | |||
| Hui-Mei Hu | |||
| P2860 | cites work | The global distribution and burden of dengue | Q24628768 |
| Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination | Q24676067 | ||
| Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity | Q26700094 | ||
| Revealing the role of CD4+ T cells in viral immunity | Q26995409 | ||
| New mouse model for dengue virus vaccine testing | Q27469339 | ||
| Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates | Q27469664 | ||
| A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3' Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys | Q27473080 | ||
| Murine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular Permeability | Q27477548 | ||
| Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus | Q27484362 | ||
| Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever | Q27486912 | ||
| The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection | Q27488224 | ||
| Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody | Q27489654 | ||
| Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease | Q27490947 | ||
| A measles virus-based vaccine candidate mediates protection against Zika virus in an allogenic mouse pregnancy model | Q58671442 | ||
| Correlation between the avidity of mouse-human chimeric IgG subclass monoclonal antibodies measured by solid-phase elution ELISA and biospecific interaction analysis (BIA) | Q73543868 | ||
| Human T Cell Response to Dengue Virus Infection | Q90266052 | ||
| Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines | Q91593468 | ||
| Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions | Q92093930 | ||
| Human IFNAR2 deficiency: Lessons for antiviral immunity | Q28114888 | ||
| STAT2 deficiency and susceptibility to viral illness in humans | Q28115608 | ||
| Cross-reacting antibodies enhance dengue virus infection in humans | Q28281588 | ||
| The global burden of dengue: an analysis from the Global Burden of Disease Study 2013 | Q28388682 | ||
| Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses | Q28729951 | ||
| Human CD4+ T cell responses to an attenuated tetravalent dengue vaccine parallel those induced by natural infection, in magnitude, HLA restriction and antigen specificity | Q28733418 | ||
| Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial | Q29616259 | ||
| Prospects for a dengue virus vaccine | Q29619608 | ||
| Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles | Q33358547 | ||
| T-cell immunity to infection with dengue virus in humans | Q33414009 | ||
| IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity | Q33438726 | ||
| Immunopathogenesis of Dengue hemorrhagic fever | Q33597146 | ||
| A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles | Q33769306 | ||
| Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challenges | Q33916635 | ||
| Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses | Q34129876 | ||
| CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination | Q34234563 | ||
| Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection | Q34261827 | ||
| A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies | Q34304888 | ||
| Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial | Q34428943 | ||
| Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease | Q34487028 | ||
| Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection. | Q34518791 | ||
| The global economic burden of dengue: a systematic analysis | Q34522607 | ||
| Global measles elimination | Q34579842 | ||
| Immunodomination during peripheral vaccinia virus infection. | Q34697921 | ||
| Intracellular Cytokine Production by Dengue Virus–specific T cells Correlates with Subclinical Secondary Infection | Q34754885 | ||
| Correlation between Dengue-Specific Neutralizing Antibodies and Serum Avidity in Primary and Secondary Dengue Virus 3 Natural Infections in Humans | Q34779065 | ||
| Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement | Q34999863 | ||
| Role of humoral versus cellular responses induced by a protective dengue vaccine candidate | Q35034240 | ||
| Protection and compensation in the influenza virus-specific CD8+ T cell response | Q35163418 | ||
| CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice | Q35760439 | ||
| Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors | Q35844406 | ||
| The Immunodominance Change and Protection of CD4+ T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice | Q35880666 | ||
| Recombinant Measles AIK-C Vaccine Strain Expressing the prM-E Antigen of Japanese Encephalitis Virus | Q35941078 | ||
| Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells | Q36895622 | ||
| The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection. | Q37135489 | ||
| Immune Response to Dengue Virus and Prospects for a Vaccine | Q37827145 | ||
| Vaccines for the prevention of dengue: Development update | Q37867401 | ||
| Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms | Q37901360 | ||
| The Human Antibody Response to Dengue Virus Infection | Q37987124 | ||
| Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates | Q38905831 | ||
| Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity | Q39028302 | ||
| Restriction of measles virus RNA synthesis by a mouse host cell line: trans-complementation by polymerase components or a human cellular factor(s) | Q39683763 | ||
| Evaluation of interferences between dengue vaccine serotypes in a monkey model. | Q39887927 | ||
| HLA-DRB1 Alleles Are Associated With Different Magnitudes of Dengue Virus-Specific CD4+ T-Cell Responses | Q40095654 | ||
| A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus | Q40245153 | ||
| A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates | Q40255696 | ||
| Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice | Q40302299 | ||
| Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial | Q40342385 | ||
| T lymphocyte responses to heterologous secondary dengue virus infections | Q40380093 | ||
| A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity | Q40401247 | ||
| A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates | Q40485770 | ||
| Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein | Q40510477 | ||
| Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines | Q40541517 | ||
| Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes | Q40553958 | ||
| Antibody-enhanced dengue virus infection in primate leukocytes | Q40884212 | ||
| Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. | Q40901873 | ||
| Dengue vaccine: hypotheses to understand CYD-TDV-induced protection | Q42985743 | ||
| Purification of RNA using TRIzol (TRI reagent). | Q43048322 | ||
| A digenic human immunodeficiency characterized by IFNAR1 and IFNGR2 mutations | Q47438235 | ||
| T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses. | Q47554119 | ||
| Cross-priming induces immunodomination in the presence of viral MHC class I inhibition | Q50000047 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 546 | |
| P577 | publication date | 2020-03-31 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Immunodomination of Serotype-Specific CD4+ T-Cell Epitopes Contributed to the Biased Immune Responses Induced by a Tetravalent Measles-Vectored Dengue Vaccine | |
| P478 | volume | 11 |
Search more.